Evaluating the effect of a proposed logistics fee cap on pharmaceuticals in South Africa - a pre and post analysis

Table 2 Injectable dosage forms

				Pre-Logistics Fee Regulation Prices				Post-Logistics Fee Regulation Prices
Active Ingredients	O/G	Pack Size	Ex-Manufacturers Price in 2013	Logistics Fee in 2013	SEP in 2013 (VAT incl.)	Unit Price in 2013	Logistics fee/SEP %	Logistics fee with proposed cap	SEP with proposed cap (VAT incl.)	Unit Price with proposed cap	Logistics fee with proposed cap/Sep %	Change in SEP after logistics fee cap	Overall effect on SEP after logistics fee cap
Omeprazole 40 mg/10 ml	O	100 ml	219.09	0.66	250.51	2.51	0.26	17.15	269.31	2.69	6.37	18.79	Increase
Omeprazole 40 mg/10 ml	G	10 ml	67.77	11.96	90.89	9.09	13.16	8.42	86.85	8.69	9.69	−4.03	Decrease
Diazepam 10 mg/2 ml	O	10 ml	101.43	10.62	127.73	12.77	8.313	10.1	127.12	12.71	7.93	−0.61	Decrease
Diazepam 10 mg/2 ml	G	20 ml	23.36	1.40	28.23	1.41	4.97	4.87	32.18	1.61	15.13	3.95	Increase
Ciprofloxacin 2 mg/ml	O	50 ml	74.53	6.63	92.52	1.85	7.17	8.96	95.18	1.90	9.42	2.66	Increase
Ciprofloxacin 2 mg/ml	G	50 ml	23.71	1.92	29.22	0.58	6.58	4.89	32.61	0.65	15.02	3.39	Increase
Diclofenac 75 mg/3 ml	O	15 ml	43.81	4.28	54.82	3.65	7.79	6.51	57.36	3.82	11.34	2.54	Increase
Diclofenac 75 mg/3 ml	G	150 ml	43.66	4.85	55.31	0.37	8.77	6.49	57.18	0.38	11.36	1.87	Increase
Paracetamol 500 mg/50 ml	O	100 ml	283.75	45.68	371.99	0.31	11.44	21.03	347.45	3.52	3.60	−24.54	Decrease
Salbutamol 500mcg/ml	O	5 ml	156.06	27.53	209.29	41.86	13.16	13.36	193.14	193.14	6.92	−16.15	Decreased
Ceftriaxone 1 g	O	3.5 mL	57.88	6.063	72.89	20.83	8.32	7.63	74.68	21.34	10.22	1.79	Increase
Ceftriaxone 1 g	G	3.5 mL	9.522	0.94	11.93	3.41	7.89	3.76	15.14	4.33	24.84	3.21	Increase

All Prices are in ZAR; O = Originator brand G = Generic brand; Originator injectable dosage forms: P value = 0.693; Generic injectable dosage forms: P value = 0.318

ISSN: 1472-6963